- Home
- GRAF vs DCTH Comparison
GRAF vs DCTH Comparison
Compare GRAF & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRAF
- DCTH
- Stock Information
- Founded
- GRAF 2021
- DCTH 1988
- Country
- GRAF United States
- DCTH United States
- Employees
- GRAF N/A
- DCTH N/A
- Industry
- GRAF
- DCTH Medical/Dental Instruments
- Sector
- GRAF
- DCTH Health Care
- Exchange
- GRAF NYSE
- DCTH Nasdaq
- Market Cap
- GRAF 294.4M
- DCTH 426.3M
- IPO Year
- GRAF 2024
- DCTH N/A
- Fundamental
- Price
- GRAF $10.47
- DCTH $11.03
- Analyst Decision
- GRAF
- DCTH Strong Buy
- Analyst Count
- GRAF 0
- DCTH 4
- Target Price
- GRAF N/A
- DCTH $24.00
- AVG Volume (30 Days)
- GRAF 5.1K
- DCTH 898.0K
- Earning Date
- GRAF 01-01-0001
- DCTH 08-04-2025
- Dividend Yield
- GRAF N/A
- DCTH N/A
- EPS Growth
- GRAF N/A
- DCTH N/A
- EPS
- GRAF 0.32
- DCTH N/A
- Revenue
- GRAF N/A
- DCTH $53,850,000.00
- Revenue This Year
- GRAF N/A
- DCTH $162.10
- Revenue Next Year
- GRAF N/A
- DCTH $32.97
- P/E Ratio
- GRAF $32.47
- DCTH N/A
- Revenue Growth
- GRAF N/A
- DCTH 1068.87
- 52 Week Low
- GRAF $9.03
- DCTH $7.17
- 52 Week High
- GRAF $11.02
- DCTH $18.23
- Technical
- Relative Strength Index (RSI)
- GRAF N/A
- DCTH 34.31
- Support Level
- GRAF N/A
- DCTH $11.20
- Resistance Level
- GRAF N/A
- DCTH $12.72
- Average True Range (ATR)
- GRAF 0.00
- DCTH 0.58
- MACD
- GRAF 0.00
- DCTH -0.12
- Stochastic Oscillator
- GRAF 0.00
- DCTH 22.18
About GRAF GRAF GLOBAL CORP
Graf Global Corp is a blank check company.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.